Integra LifeSciences  Corporation logo

Integra LifeSciences Corporation

IART | NASDAQ
Chart Builder DCF Calculator
$15.59
+$0.37 (+2.43%)
At close: Sep 21, 2026, 4:00 PM ET
$17
+$1.41 (+9.04%)
Pre-market: Sep 22, 2026, 6:19 AM ET

Market Data

Market Cap
$1.21B
Enterprise Value
$2.98B
Beta
1.21
Average Volume
956.47K
Shares Outstanding (Diluted)
78.17M
Shares Change YoY
2.23%
Institutional Ownership
97.20%
Exchange
NASDAQ
ISIN
US4579852082

Price Performance

Price Change 1M
-6.5%
Price Change 3M
-11.9%
Price Change 6M
63.3%
Price Change YTD
29.8%
Price Change 1Y
8.2%
Price Change 3Y
-59.6%
Price Change 5Y
-78.4%
1M CAGR (ann.)
-9.6%
1Y CAGR (ann.)
1.4%
5Y CAGR (ann.)
-25.8%
All-Time CAGR
-0.9%

Valuation

PE Ratio
-168.36
Forward PE
5.94
PEG Ratio
-1.69
Forward PEG
-27.34
PS Ratio
0.74
Forward PS
0.70
PB Ratio
1.15
P/FCF Ratio
31.29
P/Adj. FCF Ratio
44.35
P/OCF Ratio
14.30
EV/Sales
1.81
EV/EBIT
31.00
EV/EBITDA
14.14
EV/FCF
76.84
Earnings Yield
-0.6%
FCF Yield
3.2%
Adj. FCF Yield
2.3%

Financial Health

Net Debt
$1.59B
Total Debt
$2.04B
Cash & Short-Term Investments
$274.08M
Total Assets
$3.59B
Current Ratio
3.40
Quick Ratio
1.98
Debt / Equity Ratio
1.94
Debt / EBITDA
9.68
Debt / FCF
52.62
OCF / Debt
0.04
Interest Coverage
6.82
Altman Z-Score
1.28
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
53.7%
Operating Profit Margin
39.8%
EBITDA Margin
15.1%
Net Profit Margin
-0.4%
FCF Margin
2.4%
Adj. FCF Margin
1.7%
SBC / Revenue
0.7%
SBC Impact (per share)
-29.5%

Returns

Return on Assets
-0.2%
Return on Equity
-0.7%
Return on Invested Capital
19.9%
Return on Capital Employed
20.3%
Return on Tangible Assets
-0.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
2.2%
Revenue CAGR 5Y
1.8%
Revenue CAGR 10Y
5.6%
EPS CAGR 3Y
-9.0%
EPS CAGR 5Y
-217.7%
EPS CAGR 10Y
-150.6%
FCF CAGR 3Y
-37.0%
FCF CAGR 5Y
-32.8%
FCF CAGR 10Y
-6.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
26
EPS Growth Next 3Y
1144.4%
Revenue Growth Next 3Y
3.1%
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
$0.56
EPS Growth Est (next Q)
3.7%
Revenue Est (next Q)
$416.3M
Revenue Growth Est (next Q)
3.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$20.50
Price Target Upside
31.5%

Cash Flow

Operating Cash Flow
$85.33M
Free Cash Flow
$38.76M
Adj. Free Cash Flow
$27.34M
FCF Per Share
$0.50
OCF Per Share
$1.09
OCF/S Ratio
5.2%

Income Statement

Revenue
$1.65B
Gross Profit
$885.45M
Operating Income
$655.86M
EBITDA
$210.66M
Net Income
$-7.24M
EPS (Diluted)
-$0.09
Revenue / Employee
$372.19K
Profit / Employee
$-1.64K
Employees
4,427

© 2026 bestshares.com. All rights reserved.